Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51.6M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2.01M
-
Shares change
-
+111K
-
Total reported value, excl. options
-
$9.82M
-
Value change
-
-$105K
-
Put/Call ratio
-
0
-
Number of buys
-
17
-
Number of sells
-
-16
-
Price
-
$4.88
Significant Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q2 2022
40 filings reported holding ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share as of Q2 2022.
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.01M shares
of 51.6M outstanding shares and own 3.9% of the company stock.
Largest 10 shareholders include Shay Capital LLC (396K shares), VANGUARD GROUP INC (351K shares), PERKINS CAPITAL MANAGEMENT INC (228K shares), Long Focus Capital Management, LLC (178K shares), 683 Capital Management, LLC (125K shares), WELLS FARGO & COMPANY/MN (125K shares), Clearline Capital LP (120K shares), LPL Financial LLC (102K shares), GEODE CAPITAL MANAGEMENT, LLC (85.6K shares), and ROYAL BANK OF CANADA (50.4K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.